Business Wire - Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® 50 mg/day For The Treatment Of Major Depressive Disorder In Adults

May 7, 2012 --

These and Other PRISTIQ Data Presented for the First Time at the 165(th) Annual Meeting of the American Psychiatric Association (APA)

...

continue reading